Enzi Wealth’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $276K | Buy |
1,432
+17
| +1% | +$3.27K | 0.1% | 56 |
|
2025
Q1 | $255K | Sell |
1,415
-44
| -3% | -$7.94K | 0.1% | 56 |
|
2024
Q4 | $247K | Sell |
1,459
-1
| -0.1% | -$169 | 0.09% | 61 |
|
2024
Q3 | $286K | Buy |
1,460
+11
| +0.8% | +$2.15K | 0.11% | 53 |
|
2024
Q2 | $242K | Buy |
1,449
+86
| +6% | +$14.4K | 0.11% | 57 |
|
2024
Q1 | $220K | Buy |
1,363
+1
| +0.1% | +$162 | 0.1% | 53 |
|
2023
Q4 | $236K | Buy |
1,362
+1
| +0.1% | +$173 | 0.11% | 52 |
|
2023
Q3 | $201K | Buy |
+1,361
| New | +$201K | 0.11% | 50 |
|
2023
Q2 | – | Sell |
-1,461
| Closed | -$235K | – | 59 |
|
2023
Q1 | $235K | Buy |
1,461
+3
| +0.2% | +$483 | 0.12% | 60 |
|
2022
Q4 | $215K | Buy |
1,458
+12
| +0.8% | +$1.77K | 0.1% | 66 |
|
2022
Q3 | $217K | Buy |
+1,446
| New | +$217K | 0.11% | 68 |
|